Diet drug duke-out

When you're a pharmaceutical company hoping to turn a profit on a controversial product, your work never stops, it would appear. Although, I suppose that's true of any pharmaceutical company nowadays... GlaxoSmithKline, marketers of the over-the-counter weight-loss drug alli, which we linkurl:profiled;http://www.nj.com/news/index.ssf/2008/06/consumers_face_a_bewildering_a.html in last month's issue, is asking the FDA to force weight-loss supplement sellers to conduct clinical trials